Literature DB >> 23220287

Urinary kidney injury molecule 1 and incidence of heart failure in elderly men.

Axel C Carlsson1, Anders Larsson, Johanna Helmersson-Karlqvist, Lars Lind, Erik Ingelsson, Tobias E Larsson, Johan Sundström, Johan Arnlöv.   

Abstract

AIMS: There is growing recognition of the clinical importance of cardiorenal syndrome-the bidirectional interplay between kidney and cardiac dysfunction. Yet, the role of kidney tubular damage in the development of heart failure is less studied. The objective of this study was to investigate whether urinary kidney injury molecule (KIM)-1, a specific marker of tubular damage, predisposes to an increased heart failure risk. METHODS AND
RESULTS: This was a community-based cohort study [Uppsala Longitudinal study of Adult Men (ULSAM)] of 565, 77-year-old men free from heart failure at baseline. Heart failure hospitalizations were used as outcome. During follow-up (median 8.0 years), 73 participants were hospitalized for heart failure. In models adjusted for cardiovascular risk factors (age, systolic blood pressure, diabetes, smoking, body mass index, LDL/HDL ratio, antihypertensive treatment, lipid-lowering treatment, aspirin treatment, LV hypertrophy, and prevalent cardiovascular disease) and markers of kidney dysfunction and damage [cystatin C-based glomerular filtration rate (GFR) and urinary albumin/creatinine ratio], a higher urinary KIM-1/creatinine ratio was associated with higher risk for heart failure (hazard ratio upper vs. lower tertile, 1.81; 95% confidence interval 1.01-3.29; P < 0.05). Participants with a combination of low GFR (<60 mL/min/1.72 m(2)) and high KIM-1/creatinine (>128 ng/mmol) had a 3-fold increase in heart failure risk compared with participants with normal GFR and KIM-1 (P < 0.001).
CONCLUSION: Our findings suggest that kidney tubular damage predisposes to an increased risk for heart failure in the community. Further studies are needed to clarify the causal role of KIM-1 in the development of heart failure, and to evaluate the clinical utility of urinary KIM-1 measurements.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220287     DOI: 10.1093/eurjhf/hfs187

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  15 in total

1.  Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study.

Authors:  Todd H Driver; Ronit Katz; Joachim H Ix; Jared W Magnani; Carmen A Peralta; Chirag R Parikh; Linda Fried; Anne B Newman; Stephen B Kritchevsky; Mark J Sarnak; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2014-03-18       Impact factor: 8.860

2.  Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.

Authors:  Sushrut S Waikar; Venkata Sabbisetti; Johan Ärnlöv; Axel C Carlsson; Josef Coresh; Harold I Feldman; Meredith C Foster; Gudeta D Fufaa; Johanna Helmersson-Karlqvist; Chi-Yuan Hsu; Paul L Kimmel; Anders Larsson; Yumin Liu; Lars Lind; Kathleen D Liu; Theodore E Mifflin; Robert G Nelson; Ulf Risérus; Ramachandran S Vasan; Dawei Xie; Xiaoming Zhang; Joseph V Bonventre
Journal:  Nephrol Dial Transplant       Date:  2016-06-07       Impact factor: 5.992

3.  Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Kathleen D Liu; Wei Yang; Alan S Go; Amanda H Anderson; Harold I Feldman; Michael J Fischer; Jiang He; Radhakrishna R Kallem; John W Kusek; Stephen R Master; Edgar R Miller; Sylvia E Rosas; Susan Steigerwalt; Kaixiang Tao; Matthew R Weir; Chi-Yuan Hsu
Journal:  Am J Kidney Dis       Date:  2014-10-11       Impact factor: 8.860

4.  Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men.

Authors:  Axel C Carlsson; Anders Larsson; Johanna Helmersson-Karlqvist; Lars Lind; Erik Ingelsson; Tobias E Larsson; Matteo Bottai; Johan Sundström; Johan Ärnlöv
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 8.237

Review 5.  Novel renal biomarkers to assess cardiorenal syndrome.

Authors:  Meredith A Brisco; Jeffrey M Testani
Journal:  Curr Heart Fail Rep       Date:  2014-12

6.  Methionine restriction delays senescence and suppresses the senescence-associated secretory phenotype in the kidney through endogenous hydrogen sulfide.

Authors:  Si-Yang Wang; Wen-Juan Wang; Jie-Qiong Liu; Yu-Huan Song; Ping Li; Xue-Feng Sun; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Cell Cycle       Date:  2019-06-05       Impact factor: 4.534

7.  Associations of Circulating Protein Levels With Lipid Fractions in the General Population.

Authors:  Sylwia M Figarska; Stefan Gustafsson; Johan Sundström; Johan Ärnlöv; Anders Mälarstig; Sölve Elmståhl; Tove Fall; Lars Lind; Erik Ingelsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 8.  New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.

Authors:  Deepa M Gopal; Flora Sam
Journal:  J Cardiovasc Transl Res       Date:  2013-04-23       Impact factor: 4.132

9.  Biomarkers of Endothelial, Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure.

Authors:  Ryan McMillan; Leonidas Skiadopoulos; Debra Hoppensteadt; Nil Guler; Vinod Bansal; Ravipresenna Parasuraman; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2017-10-08       Impact factor: 2.389

10.  Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.

Authors:  Dustin L Cooper; Derek E Murrell; Christopher M Conder; Victoria E Palau; Grace E Campbell; Shaun P Lynch; James W Denham; Angela V Hanley; Kenny W Bullins; Peter C Panus; Krishna Singh; Sam Harirforoosh
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.